adenocarcinoma of esophagogastric junction
Showing 1 - 11 of 11
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Jul 25, 2023
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- S1
- +3 more
-
Hangzhou, Zhejiang, China
- +4 more
May 23, 2023
Proximal Gastric Adenocarcinoma, Adenocarcinoma of Esophagogastric Junction, Anastomosis Trial in Beijing ("arch-bridge-type"
Recruiting
- Proximal Gastric Adenocarcinoma
- +2 more
- "arch-bridge-type" esophagogastric reconstruction after proximal gastrectomy
-
Beijing, Beijing, ChinaZiyu Li
Apr 12, 2023
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency Trial in China
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Feb 7, 2023
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Feb 7, 2023
Adenocarcinoma of Esophagogastric Junction Trial in Beijing (neoadjuvant Radiation plus SOX and PD-1 antibody)
Not yet recruiting
- Adenocarcinoma of Esophagogastric Junction
- neoadjuvant Radiation plus SOX and PD-1 antibody
-
Beijing, Beijing, ChinaPeking University People's Hospital
Aug 15, 2022
Adenocarcinoma of Esophagogastric Junction Trial in Beijing (transhiatal/transabdominal approach, thoracoabdominal approach)
Recruiting
- Adenocarcinoma of Esophagogastric Junction
- transhiatal/transabdominal approach
- thoracoabdominal approach
-
Beijing, Beijing, ChinaChinese PLA General Hospital
May 29, 2021
Adenocarcinoma of Esophagogastric Junction, Neoadjuvant Chemo, Pembrolizumab Trial in Tianjin (Pembrolizumab Injection
Recruiting
- Adenocarcinoma of Esophagogastric Junction
- +2 more
- Pembrolizumab Injection [Keytruda]
-
Tianjin, Tianjin, ChinaDepartment of minimally invasive esophageal surgery, Tianjin Med
Mar 22, 2021
B Cell Lymphoma, B Cell Leukemia, Myeloma Trial in Wenzhou (CAR-CD19 T cell, CAR-BCMA T cell, CAR-GPC3 T cell)
Active, not recruiting
- B Cell Lymphoma
- +5 more
- CAR-CD19 T cell
- +5 more
-
Wenzhou, Zhejiang, ChinaFirst Affiliated Hospital of Wenzhou Medical University
Oct 5, 2020
Basal Cell Carcinoma, Medulloblastoma, Adenocarcinoma of Esophagogastric Junction Trial in Chang Chun (ZSP1602)
Recruiting
- Basal Cell Carcinoma
- +5 more
-
Chang Chun, Jilin, ChinaJilin Cancer Hospital
Jul 20, 2020
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction Trial in Korea, Republic of, United States (Tesetaxel)
Unknown status
- Adenocarcinoma of the Stomach
- Adenocarcinoma of Esophagogastric Junction
-
Chicago, Illinois
- +3 more
Mar 14, 2012